Table 4

Spearman rank correlation results for six laboratory-based risk scores, each compared to non-laboratory-based risk score, men
Dataset Number Fr_CVD_08 [11] Fr_CVD_91 [10] Fr_CHD_91 [10] SCORE_h [4]a SCORE_l [4]a CUORE[12]
Aggregate 5,751 0.939 0.950 0.883 0.985 0.986 0.957
BRISK 287 0.964 0.969 0.931 0.988 0.989 0.970
CRIBSA 357 0.963 0.967 0.922 0.987 0.988 0.974
Mangaung 276 0.952 0.961 0.900 0.985 0.986 0.967
QwaQwa 247 0.951 0.960 0.896 0.988 0.989 0.967
AHA-FS Urban 90 0.895 0.896 0.835 0.960 0.962 0.969
AHA-FS Rural 151 0.906 0.903 0.797 0.967 0.968 0.959
PURE, Urban 364 0.877 0.893 0.751 0.974 0.978 0.925
PURE, Rural 326 0.910 0.919 0.818 0.977 0.980 0.938
KwaZulu-Natal 130 0.944 0.943 0.881 0.981 0.981 0.968
CRISIC 382 0.945 0.956 0.891 0.987 0.988 0.952
Mamre 296 0.957 0.966 0.919 0.986 0.987 0.952
KORIS 2,571 0.951 0.959 0.914 0.988 0.989 0.966
Phoenix 274 0.959 0.962 0.921 0.963 0.966 0.971

aFramingham 10-year CVD risk of >20% of fatal and non-fatal events is equivalent to 5% risk of fatal events for SCORE. CHD coronary heart disease, CVD cardiovascular disease, Fr Framingham.

Gaziano et al.

Gaziano et al. BMC Medicine 2013 11:170   doi:10.1186/1741-7015-11-170

Open Data